Blog

When you say Intuit, many investors think of the familiar TurboTax or QuickBooks – software tools that help people and businesses manage taxes and accounting. But beneath the surface of this seemingly boring administration, the story of one of the most dynamic companies of today is taking place today. A story that has more and more to do with artificial intelligence, vision and investment perspective.

April's results of the European car market, compiled by the analytical company JATO Dynamics, revealed a breakthrough change. BYD, which originated in China, in this key market, in sales of battery electric vehicles (BEVs), surpassed Tesla for the first time, which also ranked among the top ten most frequently registered brands. In addition, these record numbers also supported the stock price itself, which made investors think – BYD or Tesla?

Just a few years ago, 23andMe was synonymous with a pioneer in the field of genetic testing for consumers. Its IPO took place in 2021, and at the peak of its performance, the company boasted a total value of around $6 billion, but since then the dream has gradually crumbled. The troubled period began with a massive leak of sensitive data of its customers, later the situation worsened financially, and bankruptcy is currently underway, in which Regeneron is involved. Will it help?

On Tuesday, May 13, 2025, the United States and Saudi Arabia announced the conclusion of a strategic economic partnership worth $600 billion. A key part of this package are large-scale agreements on cooperation in the field of artificial intelligence (AI), which can fundamentally reshape not only Saudi Arabia's position in the global technology rankings, but also the direction of American AI companies, geopolitical tensions with China, and the future of AI infrastructure in the wider Middle East region.

While technology stocks exceled and the S&P 500 or Nasdaq Composite have erased most of this year’s losses due to trade deal hopes between the US and China, the Dow Jones Industrial Average (DJI) has not yet been hit by this optimism. As of May 14, 2025, it has fallen by another 0.64% and so far, it does not look like its situation will improve anytime soon. This is mainly due to the sharp fall in shares of UnitedHealth Group, the largest American health insurance company.